Clinical trials
Infertile Females or Females With Ovarian Insufficiency clinical trials
Below are recruiting infertile females or females with ovarian insufficiency clinical trials, each written for real people, not researchers. We’re tracking 163 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07494877Recruiting
Anticoagulant therapy for infertility in women aged 20-45
This study looks at whether blood-thinning medication can improve the chance of pregnancy in women who have trouble conceiving. It focuses on how the medication affects the lining of the womb and its ability to accept an embryo.
Xi'an, ShaanxiAges 20–45 - NCT07469007Recruiting
How surgery for deep endometriosis affects egg supply
This trial looks at how surgery for deep endometriosis behind the uterus affects a woman's egg supply (ovarian reserve). It is for women with severe deep endometriosis but without large ovarian cysts or previous surgery for this condition.
Quint-FonsegrivesAges 18–39 - NCT07456397Recruiting
AI to predict sperm success in IVF
This trial tests a new AI system that analyzes sperm to predict how well they might work in fertility treatments like IVF or ICSI. It aims to help doctors choose the best sperm for a successful pregnancy.
Barcelona, BarcelonaAges 18–60 - NCT07376824RecruitingPhase 3
Acupoint light therapy and Chinese medicine for ovarian reserve
This trial tests whether combining acupoint photodynamic therapy with traditional Chinese medicine can improve ovarian reserve in women with diminished ovarian reserve. It aims to find a gentle, non-hormonal way to support fertility.
Beijing, Beijing MunicipalityAges 25–40 - NCT07171528RecruitingPhase 2
Surgery after chemo for recurrent ovarian cancer
This trial is for people with recurrent ovarian cancer whose disease came back more than 6 months after platinum chemo. It tests whether removing the recurrent tumor with surgery (after more chemo) can help—even if surgery wasn't an option before.
Goyang-si, Gyeonggi-doAges 19–80 - NCT07002346RecruitingPhase 3
Immunotherapy and bevacizumab for advanced ovarian clear cell cancer
This trial tests a combination of an immunotherapy drug (QL1706) and a targeted therapy (bevacizumab) for women with newly diagnosed advanced ovarian clear cell carcinoma. The goal is to see if this combination works better than standard treatment after surgery.
Wuhan, HubeiAges 18–75 - NCT06975683Recruiting
PRGF ovarian injection for low ovarian reserve
This study tests a special injection of growth factors from your own blood into the ovary to see if it can improve egg quality and quantity for women with low ovarian reserve. It may be an option if you have been trying to conceive for over a year and have low egg reserve.
MadridAges 18–50 - NCT05726305Recruiting
Uterus transplant for women who cannot carry a pregnancy
This trial studies transplanting a uterus to allow people with uterine infertility to try pregnancy. It may help some patients who cannot carry a baby because their uterus is missing or nonfunctional, but it requires careful matching and strict health screening for both recipients and donors.
RennesAges 18 years+ - NCT06742788Recruiting
Vagus nerve stimulation for IVF patients with anxiety or depression
This trial tests whether a gentle form of nerve stimulation (taVNS) can improve pregnancy rates in women undergoing IVF who also have mild-to-moderate anxiety or depression. It aims to see if this treatment is both helpful and practical for this group.
Xi'an, ShaanxiAges 20–40 - NCT06717802Recruiting
AI to predict when the womb is ready for IVF
This study uses artificial intelligence to find the best time to transfer an embryo during IVF. It may help people who have had up to 3 unsuccessful transfers before.
BudapestAges 18–40 - NCT06234423RecruitingPhase 1
A study of CUSP06 for advanced solid tumors
This study tests a new drug called CUSP06 for people with advanced solid tumors, especially ovarian cancer that has stopped responding to platinum chemotherapy. It may help if standard treatments no longer work.
Denver, ColoradoAges 18 years+ - NCT06083844RecruitingPhase 2
Keytruda + Avastin + chemo for ovarian cancer with minimal remaining disease
This trial tests a combination of three drugs—pembrolizumab (Keytruda, an immunotherapy), bevacizumab (Avastin, a blood-vessel blocker), and oral cyclophosphamide (a chemotherapy pill)—for women with high-grade ovarian cancer who have only tiny bits of disease left after finishing their initial treatment.
New York, New YorkAges 18 years+ - NCT05952453RecruitingPhase 2
New ovarian cancer treatment with chemo plus maintenance medicines
This Phase 2 trial tests giving chemotherapy before surgery, then continuing two medicines afterward (olaparib and pembrolizumab). It’s designed for people with newly diagnosed Stage III/IV ovarian, fallopian tube, or primary peritoneal cancer who may benefit from tighter control of the disease.
Birmingham, AlabamaAges 18 years+ - NCT05646992RecruitingPhase 2/Phase 3
Uterus transplant study to help infertility
This study tests whether transplanting a uterus can help people who cannot carry a pregnancy become pregnant and give birth. It involves surgery plus medicines to help the body accept the new organ, and then embryo transfer to try to achieve pregnancy.
Baltimore, MarylandAges 18–38 - NCT05460000RecruitingPhase 2
Niraparib after early ovarian cancer chemo—short vs long
This trial tests whether taking niraparib (a maintenance anti-cancer pill) for a shorter time after 3 cycles of platinum chemotherapy works as well as taking it after 6 cycles. It is for people with advanced ovarian cancer that has been fully removed (no visible tumor) and is “HRD-positive,” meaning it has certain DNA repair weaknesses.
InnsbruckAges 18 years+ - NCT05263076Recruiting
Uterus transplant trial for women born without a working uterus
This trial studies uterus transplant surgery to help people with “absolute uterine factor infertility” (no working uterus) become pregnant using embryos made by IVF. It checks whether the donated uterus can support pregnancy and safe delivery for participants who meet strict medical and health requirements.
Houston, TexasAges 20–65 - NCT05071937RecruitingPhase 2
Talazoparib plus ZEN003694 for recurrent ovarian cancer
This Phase 2 trial tests whether combining ZEN003694 with talazoparib can slow or shrink recurrent ovarian, fallopian tube, or primary peritoneal cancer. It is designed for people who have already been treated with a PARP inhibitor before, and it may help if that cancer comes back.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT04298255Recruiting
Testicular injection therapy for certain causes of male infertility
This trial studies a special lab procedure where selected immature sperm cells are injected to help infertile couples achieve pregnancy. It is designed for couples where the man has a specific type of sperm-making problem found during a testicular sperm extraction.
Winston-Salem, North CarolinaAges 18 years+ - NCT06187870Recruiting
Biobank for urological and cancer research
This study collects blood, urine, and tissue samples from patients with urological diseases or cancers to build a biobank for future research. It may help researchers better understand these conditions and develop new treatments.
Milan, LombardyAges 18 years+ - NCT06144268Recruiting
Sperm selection for intrauterine insemination
This trial tests a device called ZyMōt Multi that selects the best sperm for intrauterine insemination (IUI). It may help couples trying to conceive by improving the chance of a live birth.
BrusselsAges 18–36 - NCT05599438Recruiting
Fitness and drug use study in recreational athletes
This study follows recreational athletes to understand how past and current anabolic-androgenic steroid (AAS) use relates to fitness changes over time. If you have used these substances in the past (and stopped more than 3 months ago), or you have never used them, you may be able to join.
CopenhagenAges 18 years+ - NCT06360471Recruiting
Preserving fertility in women with cancer
This study helps women with cancer keep their ability to have children after treatment. It offers egg or embryo freezing and checks on pregnancy and baby health later on.
Nanjing, JiangsuAges 20–40 - NCT06384794Recruiting
ZyMōt sperm selection and its effect on embryo chromosome health
This study tests whether a sperm selection method called ZyMōt can help improve the chromosome health (ploidy) of embryos in couples who are already doing ICSI and PGT-A. It focuses on women over 37 and uses a fresh semen sample.
MadridAges 18 years+ - NCT07844083Recruiting
Artificial intelligence for choosing embryos in first ivf cycle
This trial uses artificial intelligence to help doctors pick the best embryo to transfer on day 5 of development. It aims to improve the chances of a successful pregnancy in your first IVF or ICSI cycle.
Clermont-FerrandAges 18–37
Hear when a new Infertile Females or Females With Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infertile females or females with ovarian insufficiency?
- Yes. Clin2 currently lists 163 recruiting infertile females or females with ovarian insufficiency studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infertile females or females with ovarian insufficiency trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infertile females or females with ovarian insufficiency trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.